Efficient expansion and delayed senescence of hUC-MSCs by microcarrier-bioreactor system.
Bioreactor
Cell culture
Cell senescence
Human umbilical cord mesenchymal stem cells
Microcarrier
Transcriptome
Journal
Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581
Informations de publication
Date de publication:
04 10 2023
04 10 2023
Historique:
received:
06
06
2023
accepted:
25
09
2023
medline:
6
10
2023
pubmed:
5
10
2023
entrez:
4
10
2023
Statut:
epublish
Résumé
Human umbilical cord mesenchymal stem cells (hUC-MSCs) are widely used in cell therapy due to their robust immunomodulatory and tissue regenerative capabilities. Currently, the predominant method for obtaining hUC-MSCs for clinical use is through planar culture expansion, which presents several limitations. Specifically, continuous cell passaging can lead to cellular aging, susceptibility to contamination, and an absence of process monitoring and control, among other limitations. To overcome these challenges, the technology of microcarrier-bioreactor culture was developed with the aim of ensuring the therapeutic efficacy of cells while enabling large-scale expansion to meet clinical requirements. However, there is still a knowledge gap regarding the comparison of biological differences in cells obtained through different culture methods. We developed a culture process for hUC-MSCs using self-made microcarrier and stirred bioreactor. This study systematically compares the biological properties of hUC-MSCs amplified through planar culture and microcarrier-bioreactor systems. Additionally, RNA-seq was employed to compare the differences in gene expression profiles between the two cultures, facilitating the identification of pathways and genes associated with cell aging. The findings revealed that hUC-MSCs expanded on microcarriers exhibited a lower degree of cellular aging compared to those expanded through planar culture. Additionally, these microcarrier-expanded hUC-MSCs showed an enhanced proliferation capacity and a reduced number of cells in the cell cycle retardation period. Moreover, bioreactor-cultured cells differ significantly from planar cultures in the expression of genes associated with the cytoskeleton and extracellular matrix. The results of this study demonstrate that our microcarrier-bioreactor culture method enhances the proliferation efficiency of hUC-MSCs. Moreover, this culture method exhibits the potential to delay the process of cell aging while preserving the essential stem cell properties of hUC-MSCs.
Sections du résumé
BACKGROUND
Human umbilical cord mesenchymal stem cells (hUC-MSCs) are widely used in cell therapy due to their robust immunomodulatory and tissue regenerative capabilities. Currently, the predominant method for obtaining hUC-MSCs for clinical use is through planar culture expansion, which presents several limitations. Specifically, continuous cell passaging can lead to cellular aging, susceptibility to contamination, and an absence of process monitoring and control, among other limitations. To overcome these challenges, the technology of microcarrier-bioreactor culture was developed with the aim of ensuring the therapeutic efficacy of cells while enabling large-scale expansion to meet clinical requirements. However, there is still a knowledge gap regarding the comparison of biological differences in cells obtained through different culture methods.
METHODS
We developed a culture process for hUC-MSCs using self-made microcarrier and stirred bioreactor. This study systematically compares the biological properties of hUC-MSCs amplified through planar culture and microcarrier-bioreactor systems. Additionally, RNA-seq was employed to compare the differences in gene expression profiles between the two cultures, facilitating the identification of pathways and genes associated with cell aging.
RESULTS
The findings revealed that hUC-MSCs expanded on microcarriers exhibited a lower degree of cellular aging compared to those expanded through planar culture. Additionally, these microcarrier-expanded hUC-MSCs showed an enhanced proliferation capacity and a reduced number of cells in the cell cycle retardation period. Moreover, bioreactor-cultured cells differ significantly from planar cultures in the expression of genes associated with the cytoskeleton and extracellular matrix.
CONCLUSIONS
The results of this study demonstrate that our microcarrier-bioreactor culture method enhances the proliferation efficiency of hUC-MSCs. Moreover, this culture method exhibits the potential to delay the process of cell aging while preserving the essential stem cell properties of hUC-MSCs.
Identifiants
pubmed: 37794520
doi: 10.1186/s13287-023-03514-1
pii: 10.1186/s13287-023-03514-1
pmc: PMC10552362
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
284Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
De Luca M, Aiuti A, Cossu G, et al. Advances in stem cell research and therapeutic development. Nat Cell Biol. 2019;21(7):801–11. https://doi.org/10.1038/s41556-019-0344-z .
doi: 10.1038/s41556-019-0344-z
pubmed: 31209293
Pittenger MF, Discher DE, Peault BM, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22. https://doi.org/10.1038/s41536-019-0083-6 .
doi: 10.1038/s41536-019-0083-6
pubmed: 31815001
pmcid: 6889290
Naji A, Eitoku M, Favier B, et al. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019;76(17):3323–48. https://doi.org/10.1007/s00018-019-03125-1 .
doi: 10.1007/s00018-019-03125-1
pubmed: 31055643
Mastrolia I, Foppiani EM, Murgia A, et al. Challenges in clinical development of mesenchymal stromal/stem cells: concise review. Stem Cells Transl Med. 2019;8(11):1135–48. https://doi.org/10.1002/sctm.19-0044 .
doi: 10.1002/sctm.19-0044
pubmed: 31313507
pmcid: 6811694
Lam AT, Lee AP, Jayaraman P, et al. Multiomics analyses of cytokines, genes, miRNA, and regulatory networks in human mesenchymal stem cells expanded in stirred microcarrier-spinner cultures. Stem Cell Res. 2021;53:102272. https://doi.org/10.1016/j.scr.2021.102272 .
doi: 10.1016/j.scr.2021.102272
pubmed: 33676128
Mizukami A, Orellana MD, Caruso SR, et al. Efficient expansion of mesenchymal stromal cells in a disposable fixed bed culture system. Biotechnol Prog. 2013;29(2):568–72. https://doi.org/10.1002/btpr.1707 .
doi: 10.1002/btpr.1707
pubmed: 23420706
Osiecki MJ, Michl TD, Kul Babur B, et al. Packed bed bioreactor for the isolation and expansion of placental-derived mesenchymal stromal cells. PLoS One. 2015;10(12):e0144941. https://doi.org/10.1371/journal.pone.0144941 .
doi: 10.1371/journal.pone.0144941
pubmed: 26660475
pmcid: 4687640
Theodoridis K, Aggelidou E, Manthou M, et al. Assessment of cartilage regeneration on 3D collagen-polycaprolactone scaffolds: evaluation of growth media in static and in perfusion bioreactor dynamic culture. Colloids Surf B Biointerfaces. 2019;183:110403. https://doi.org/10.1016/j.colsurfb.2019.110403 .
doi: 10.1016/j.colsurfb.2019.110403
pubmed: 31400614
Liao J, Guo X, Grande-Allen KJ, et al. Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering. Biomaterials. 2010;31(34):8911–20. https://doi.org/10.1016/j.biomaterials.2010.07.110 .
doi: 10.1016/j.biomaterials.2010.07.110
pubmed: 20797784
pmcid: 2953640
Mizukami A, De Abreu Neto MS, Moreira F, et al. A fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human mesenchymal stem/stromal cells. Stem Cell Rev Rep. 2018;14(1):141–3. https://doi.org/10.1007/s12015-017-9787-4 .
doi: 10.1007/s12015-017-9787-4
pubmed: 29188439
Tsai AC, Pacak CA. Bioprocessing of human mesenchymal stem cells: from planar culture to microcarrier-based bioreactors. Bioengineering (Basel). 2021. https://doi.org/10.3390/bioengineering8070096 .
doi: 10.3390/bioengineering8070096
pubmed: 34356203
Rafiq QA, Coopman K, Nienow AW, et al. Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors. Biotechnol J. 2016;11(4):473–86. https://doi.org/10.1002/biot.201400862 .
doi: 10.1002/biot.201400862
pubmed: 26632496
pmcid: 4991290
Santos F, Andrade PZ, Abecasis MM, et al. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng Part C Methods. 2011;17(12):1201–10. https://doi.org/10.1089/ten.tec.2011.0255 .
doi: 10.1089/ten.tec.2011.0255
pubmed: 21895491
pmcid: 3226421
Silva Couto P, Rotondi MC, Bersenev A, et al. Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds. Biotechnol Adv. 2020. https://doi.org/10.1016/j.biotechadv.2020.107636 .
doi: 10.1016/j.biotechadv.2020.107636
pubmed: 32980437
Gu Y, Li T, Ding Y, et al. Changes in mesenchymal stem cells following long-term culture in vitro. Mol Med Rep. 2016;13(6):5207–15. https://doi.org/10.3892/mmr.2016.5169 .
doi: 10.3892/mmr.2016.5169
pubmed: 27108540
Tsai AC, Jeske R, Chen X, et al. Influence of microenvironment on mesenchymal stem cell therapeutic potency: from planar culture to microcarriers. Front Bioeng Biotechnol. 2020;8:640. https://doi.org/10.3389/fbioe.2020.00640 .
doi: 10.3389/fbioe.2020.00640
pubmed: 32671039
pmcid: 7327111
Hupfeld J, Gorr IH, Schwald C, et al. Modulation of mesenchymal stromal cell characteristics by microcarrier culture in bioreactors. Biotechnol Bioeng. 2014;111(11):2290–302. https://doi.org/10.1002/bit.25281 .
doi: 10.1002/bit.25281
pubmed: 24890974
Badenes SM, Fernandes TG, Rodrigues CAV, et al. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems. J Biotechnol. 2016;234:71–82. https://doi.org/10.1016/j.jbiotec.2016.07.023 .
doi: 10.1016/j.jbiotec.2016.07.023
pubmed: 27480342
Tian M, Yulin C. A microcarrier and a preparation method, application: China, CN115678839A [P/OL]. 2023.02.03.
Wiese DM, Ruttan CC, Wood CA, et al. Accumulating transcriptome drift precedes cell aging in human umbilical cord-derived mesenchymal stromal cells serially cultured to replicative senescence. Stem Cells Transl Med. 2019;8(9):945–58. https://doi.org/10.1002/sctm.18-0246 .
doi: 10.1002/sctm.18-0246
pubmed: 30924318
pmcid: 6708062
Fibbe WE, Shi Y. FOXO3, a molecular search for the fountain of youth. Cell Stem Cell. 2019;24(3):351–2. https://doi.org/10.1016/j.stem.2019.02.008 .
doi: 10.1016/j.stem.2019.02.008
pubmed: 30849363
Halfon S, Abramov N, Grinblat B, et al. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2010;20(1):53–66. https://doi.org/10.1089/scd.2010.0040 .
doi: 10.1089/scd.2010.0040
pubmed: 20528146
Gilbert W, Bragg R, Elmansi AM, et al. Stromal cell-derived factor-1 (CXCL12) and its role in bone and muscle biology. Cytokine. 2019;123:154783. https://doi.org/10.1016/j.cyto.2019.154783 .
doi: 10.1016/j.cyto.2019.154783
pubmed: 31336263
pmcid: 6948927
Zhao XD, Huang C, Wang RX, et al. DUSP22 promotes senescence of HS-1 skin cancer cells through triggering MAPK signaling pathway. Eur Rev Med Pharmacol Sci. 2021;25(3):1163.
pubmed: 33629281
Liu Y, Ho C, Wen D, et al. Targeting the stem cell niche: role of collagen XVII in skin aging and wound repair. Theranostics. 2022;12(15):6446–54. https://doi.org/10.7150/thno.78016 .
doi: 10.7150/thno.78016
pubmed: 36185608
pmcid: 9516244
Rivero-Segura NA, Bello-Chavolla OY, Barrera-Vázquez OS, et al. Promising biomarkers of human aging: in search of a multi-omics panel to understand the aging process from a multidimensional perspective. Ageing Res Rev. 2020;64:101164. https://doi.org/10.1016/j.arr.2020.101164 .
doi: 10.1016/j.arr.2020.101164
pubmed: 32977058
Ferrari V, Cristofani R, Tedesco B, et al. Valosin containing protein (VCP): a multistep regulator of autophagy. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23041939 .
doi: 10.3390/ijms23041939
pubmed: 36430468
pmcid: 9695828
O’connor KC. Molecular profiles of cell-to-cell variation in the regenerative potential of mesenchymal stromal cells. Stem Cells Int. 2019;2019:5924878. https://doi.org/10.1155/2019/5924878 .
doi: 10.1155/2019/5924878
pubmed: 31636675
pmcid: 6766122
Liu TM, Ng WM, Tan HS, et al. Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression. Stem Cells Dev. 2013;22(2):268–78. https://doi.org/10.1089/scd.2012.0222 .
doi: 10.1089/scd.2012.0222
pubmed: 22765508
Zhou B, Peng K, Wang G, et al. Polo Like Kinase 4 (PLK4) impairs human bone marrow mesenchymal stem cell (BMSC) viability and osteogenic differentiation. Biochem Biophys Res Commun. 2021;549:221–8. https://doi.org/10.1016/j.bbrc.2021.02.031 .
doi: 10.1016/j.bbrc.2021.02.031
pubmed: 33706192
Jeoung JY, Nam HY, Kwak J, et al. A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence. Stem Cells Dev. 2015;24(8):973–82. https://doi.org/10.1089/scd.2014.0273 .
doi: 10.1089/scd.2014.0273
pubmed: 25437011
Mademtzoglou D, Relaix F. From cyclins to CDKIs: cell cycle regulation of skeletal muscle stem cell quiescence and activation. Exp Cell Res. 2022;420(1):113275. https://doi.org/10.1016/j.yexcr.2022.113275 .
doi: 10.1016/j.yexcr.2022.113275
pubmed: 35931143
Cai H, Guo H, Deng Y, et al. RRM2 regulates osteogenesis of mouse embryo fibroblasts via the Wnt/β-catenin signaling pathway. Exp Ther Med. 2022;24(4):605. https://doi.org/10.3892/etm.2022.11542 .
doi: 10.3892/etm.2022.11542
pubmed: 36160885
pmcid: 9468855
Liu L, Michowski W, Kolodziejczyk A, et al. The cell cycle in stem cell proliferation, pluripotency and differentiation. Nat Cell Biol. 2019;21(9):1060–7. https://doi.org/10.1038/s41556-019-0384-4 .
doi: 10.1038/s41556-019-0384-4
pubmed: 31481793
pmcid: 7065707
Asai T, Liu Y, Bae N, et al. The p53 tumor suppressor protein regulates hematopoietic stem cell fate. J Cell Physiol. 2011;226(9):2215–21. https://doi.org/10.1002/jcp.22561 .
doi: 10.1002/jcp.22561
pubmed: 21660944
pmcid: 3081536
Katoh Y, Katoh M. FGFR2-related pathogenesis and FGFR2-targeted therapeutics (Review). Int J Mol Med. 2009;23(3):307–11. https://doi.org/10.3892/ijmm_00000132 .
doi: 10.3892/ijmm_00000132
pubmed: 19212647
Boyer SJ. Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships. Curr Top Med Chem. 2002;2(9):973–1000. https://doi.org/10.2174/1568026023393273 .
doi: 10.2174/1568026023393273
pubmed: 12171566
Sun J, Zhou Y, Ye Z, et al. Transforming growth factor-beta1 stimulates mesenchymal stem cell proliferation by altering cell cycle through FAK-Akt-mTOR pathway. Connect Tissue Res. 2019;60(4):406–17.
doi: 10.1080/03008207.2019.1570171
pubmed: 30642198
Koh B, Sulaiman N, Fauzi MB, et al. Three dimensional microcarrier system in mesenchymal stem cell culture: a systematic review. Cell Biosci. 2020;10:75. https://doi.org/10.1186/s13578-020-00438-8 .
doi: 10.1186/s13578-020-00438-8
pubmed: 32518618
pmcid: 7271456
Tsai HH, Yang KC, Wu MH, et al. The effects of different dynamic culture systems on cell proliferation and osteogenic differentiation in human mesenchymal stem cells. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20164024 .
doi: 10.3390/ijms20164024
pubmed: 31905846
pmcid: 6982098
Bijonowski BM, Daraiseh SI, Yuan X, et al. Size-dependent cortical compaction induces metabolic adaptation in mesenchymal stem cell aggregates. Tissue Eng Part A. 2019;25(7–8):575–87. https://doi.org/10.1089/ten.TEA.2018.0155 .
doi: 10.1089/ten.TEA.2018.0155
pubmed: 30187829
pmcid: 6482905
Yuan X, Sun L, Jeske R, et al. Engineering extracellular vesicles by three-dimensional dynamic culture of human mesenchymal stem cells. J Extracell Vesicles. 2022;11(6):e12235. https://doi.org/10.1002/jev2.12235 .
doi: 10.1002/jev2.12235
pubmed: 35716062
pmcid: 9206229
Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7. https://doi.org/10.1080/14653240600855905 .
doi: 10.1080/14653240600855905
pubmed: 16923606
Borghesan M, Ologhlen A. Integrins in senescence and aging. Cell Cycle. 2017;16(10):909–10. https://doi.org/10.1080/15384101.2017.1316573 .
doi: 10.1080/15384101.2017.1316573
pubmed: 28459356
pmcid: 5462089
Choi DH, Oh SY, Choi JK, et al. A transcriptomic analysis of serial-cultured, tonsil-derived mesenchymal stem cells reveals decreased integrin alpha3 protein as a potential biomarker of senescent cells. Stem Cell Res Ther. 2020;11(1):359. https://doi.org/10.1186/s13287-020-01860-y .
doi: 10.1186/s13287-020-01860-y
pubmed: 32807231
pmcid: 7430027
Elseberg CL, Leber J, Salzig D, et al. Microcarrier-based expansion process for hMSCs with high vitality and undifferentiated characteristics. Int J Artif Organs. 2012;35(2):93–107. https://doi.org/10.5301/ijao.5000077 .
doi: 10.5301/ijao.5000077
pubmed: 22388939
Rafiq QA, Brosnan KM, Coopman K, et al. Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor. Biotechnol Lett. 2013;35(8):1233–45. https://doi.org/10.1007/s10529-013-1211-9 .
doi: 10.1007/s10529-013-1211-9
pubmed: 23609232
Tozetti PA, Caruso SR, Mizukami A, et al. Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions. Biotechnol Progress. 2017;33(5):1358–67. https://doi.org/10.1002/btpr.2494 .
doi: 10.1002/btpr.2494
Jossen V, Schirmer C, Mostafa Sindi D, et al. Theoretical and practical issues that are relevant when scaling up hMSC microcarrier production processes. Stem Cells Int. 2016;2016:4760414. https://doi.org/10.1155/2016/4760414 .
doi: 10.1155/2016/4760414
pubmed: 26981131
pmcid: 4766353
Cierpka K, Elseberg CL, Niss K, et al. hMSC production in disposable bioreactors with regards to GMP and PAT. Chemie Ingenieur Technik. 2013;85(1–2):67–75. https://doi.org/10.1002/cite.201200151 .
doi: 10.1002/cite.201200151
Couto PS, Rotondi M, Bersenev A, et al. Expansion of human mesenchymal stem/stromal cells (hMSCs) in bioreactors using microcarriers: lessons learnt and what the future holds. Biotechnology Advances. 2020;45:107636. https://doi.org/10.1016/j.biotechadv.2020.107636 .
doi: 10.1016/j.biotechadv.2020.107636
Song L, Yuan X, Jones Z, et al. Functionalization of brain region-specific spheroids with isogenic microglia-like cells. Sci Rep. 2019;9(1):11055. https://doi.org/10.1038/s41598-019-47444-6 .
doi: 10.1038/s41598-019-47444-6
pubmed: 31363137
pmcid: 6667451
Bejoy J, Yuan X, Song L, et al. Genomics analysis of metabolic pathways of human stem cell-derived microglia-like cells and the integrated cortical spheroids. Stem Cells Int. 2019;2019:2382534. https://doi.org/10.1155/2019/2382534 .
doi: 10.1155/2019/2382534
pubmed: 31827525
pmcid: 6885849
Wrzesinski K, Fey SJ. Metabolic reprogramming and the recovery of physiological functionality in 3D cultures in micro-bioreactors. Bioengineering (Basel). 2018. https://doi.org/10.3390/bioengineering5010022 .
doi: 10.3390/bioengineering5010022
pubmed: 29518979
Kim MH, Kino-Oka M, Taya M. Designing culture surfaces based on cell anchoring mechanisms to regulate cell morphologies and functions. Biotechnol Adv. 2010;28(1):7–16. https://doi.org/10.1016/j.biotechadv.2009.08.002 .
doi: 10.1016/j.biotechadv.2009.08.002
pubmed: 19686833
Wong JY, Leach JB, Brown XQ. Balance of chemistry, topography, and mechanics at the cell–biomaterial interface: Issues and challenges for assessing the role of substrate mechanics on cell response. Surface Sci. 2004;570(1–2):119–33. https://doi.org/10.1016/j.susc.2004.06.186 .
doi: 10.1016/j.susc.2004.06.186
Lam AT, Sim EJ, Shekaran A, et al. Sub-confluent culture of human mesenchymal stromal cells on biodegradable polycaprolactone microcarriers enhances bone healing of rat calvarial defect. Cytotherapy. 2019;21(6):631–42. https://doi.org/10.1016/j.jcyt.2019.03.004 .
doi: 10.1016/j.jcyt.2019.03.004
pubmed: 30975604
Lin YM, Lim JF, Lee J, et al. Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells. Cytotherapy. 2016;18(6):740–53. https://doi.org/10.1016/j.jcyt.2016.03.293 .
doi: 10.1016/j.jcyt.2016.03.293
pubmed: 27173750
Liu J, Ding Y, Liu Z, et al. Senescence in mesenchymal stem cells: functional alterations, molecular mechanisms, and rejuvenation strategies. Front Cell Dev Biol. 2020;8:258. https://doi.org/10.3389/fcell.2020.00258 .
doi: 10.3389/fcell.2020.00258
pubmed: 32478063
pmcid: 7232554
Liao N, Shi Y, Zhang C, et al. Antioxidants inhibit cell senescence and preserve stemness of adipose tissue-derived stem cells by reducing ROS generation during long-term in vitro expansion. Stem Cell Res Ther. 2019;10(1):306. https://doi.org/10.1186/s13287-019-1404-9 .
doi: 10.1186/s13287-019-1404-9
pubmed: 31623678
pmcid: 6798439
Yang X, Jiang T, Wang Y, et al. The role and mechanism of SIRT1 in resveratrol-regulated osteoblast autophagy in osteoporosis rats. Sci Rep. 2019;9(1):18424. https://doi.org/10.1038/s41598-019-44766-3 .
doi: 10.1038/s41598-019-44766-3
pubmed: 31804494
pmcid: 6895060
Liu X, Hu D, Zeng Z, et al. SRT1720 promotes survival of aged human mesenchymal stem cells via FAIM: a pharmacological strategy to improve stem cell-based therapy for rat myocardial infarction. Cell Death Dis. 2017;8(4):e2731. https://doi.org/10.1038/cddis.2017.107 .
doi: 10.1038/cddis.2017.107
pubmed: 28383554
pmcid: 5477573
Zhang D, Yan B, Yu S, et al. Coenzyme Q10 inhibits the aging of mesenchymal stem cells induced by D-galactose through Akt/mTOR signaling. Oxid Med Cell Longev. 2015;2015:867293. https://doi.org/10.1155/2015/867293 .
doi: 10.1155/2015/867293
pubmed: 25789082
pmcid: 4348608
Nakazawa H, Ikeda K, Shinozaki S, et al. Coenzyme Q10 protects against burn-induced mitochondrial dysfunction and impaired insulin signaling in mouse skeletal muscle. FEBS Open Bio. 2019;9(2):348–63. https://doi.org/10.1002/2211-5463.12580 .
doi: 10.1002/2211-5463.12580
pubmed: 30761259
pmcid: 6356165
Zheng Z, Wang X, Ouyang L, et al. Antioxidants improve the proliferation and efficacy of hUC-MSCs against H2O2-induced senescence. Antioxidants. 2023;12(7):1334. https://doi.org/10.3390/antiox12071334 .
doi: 10.3390/antiox12071334
pubmed: 37507874
pmcid: 10376626
Li X, Zhan J, Hou Y, et al. Coenzyme Q10 regulation of apoptosis and oxidative stress in H(2)O(2) induced BMSC death by modulating the Nrf-2/NQO-1 signaling pathway and its application in a model of spinal cord injury. Oxid Med Cell Longev. 2019;2019:6493081. https://doi.org/10.1155/2019/6493081 .
doi: 10.1155/2019/6493081
pubmed: 31915512
pmcid: 6930770